• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT XIENCE SIERRA EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT XIENCE SIERRA EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT SYSTEM Back to Search Results
Catalog Number 1550250-33
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Angina (1710); Death (1802); Ischemia (1942); Thrombosis (2100)
Event Date 03/10/2019
Event Type  Death  
Manufacturer Narrative
(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.Concomitant medical products: stent: xience sierra: 2.5x33, 3.0x38; aspirin, brilinta.The device was not returned for evaluation.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.The reported patient effects of angina, death, ischemia, and thrombosis are listed in the sierra, everolimus eluting coronary stent systems instructions for use, as known patient effects of coronary stenting procedures.A conclusive cause for the reported patient effects and the relationship to the product, if any, cannot be determined.There is no indication of a product quality issue with respect to manufacture, design or labeling.The 2.5x33mm ans 3.0x38mm xience sierra stents referenced are filed under separate medwatch reports.
 
Event Description
It was reported that the patient was admitted on (b)(6) 2019, with st elevation myocardial infarction (stemi).Coronary intervention was performed, and two xience sierra stents (2.5x33mm, 3.0x38mm) were implanted in the proximal left anterior descending (lad) artery, in an overlapping fashion.A 2.5x33mm xience sierra stent was implanted in the first obtuse marginal (om1) artery.Post dilatation was performed per facility protocol, at both lesions.The activated clotting time (act) was noted to be 225 on the first measurement, and 290 on the second.Aspirin and brilinta were administered.Two days post procedure, the patient had complaints of worsening chest pain.Coronary angiography was performed and noted thrombus in the lad and om1.Balloon angioplasty was performed.Although poor flow was noted, the vessels were opened.The act was noted to be 400.An integrilin drip was started.On (b)(6) 2019, the patient had complaints of jaw pain and died.Cause of death was related to weakened condition from the admitting stemi, stent thrombosis, and pulmonary embolus.Per physician, the pulmonary embolus was not related to the implanted stent.No additional information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE SIERRA EVEROLIMUS ELUTING CORONARY STENT SYSTEM
Type of Device
DRUG ELUTING CORONARY STENT SYSTEM
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 4628
Manufacturer (Section G)
CLONMEL, IRELAND REG# 9616693
abbott vascular
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
connie speck
abbott vascular
26531 ynez road
temecula, CA 92591-4628
9519143996
MDR Report Key8562489
MDR Text Key143514043
Report Number2024168-2019-03392
Device Sequence Number1
Product Code NIQ
UDI-Device Identifier08717648227134
UDI-Public08717648227134
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Remedial Action Other
Type of Report Initial
Report Date 04/29/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/29/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date09/26/2019
Device Catalogue Number1550250-33
Device Lot Number8091941
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/11/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/01/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age58 YR
-
-